Dr. Fariba Navid, MD
Claim this profileChildren's Hospital Los Angeles
Expert in Cancer
Expert in Relapse
29 reported clinical trials
40 drugs studied
About Fariba Navid, MD
Education:
- Earned an MD from Tulane Medical School, New Orleans, Louisiana.
- Completed a Clinical Fellowship in Pediatric Oncology at the National Cancer Institute, Bethesda, MD.
Experience:
- Serves as Assistant Director of the Clinical Trials Program and COG Phase I & Pilot Consortium at Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles (CHLA) since September 2016.
- Holds the position of Associate Professor of Clinical Pediatrics at the Keck School of Medicine, University of Southern California.
- Has extensive experience in research and pediatric early-phase drug development, including previous work at St. Jude Children's Research Hospital.
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Relapse
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Fariba Navid, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Tiragolumab + Atezolizumab
for Solid Tumors
This trial studies how well tiragolumab and atezolizumab work in children and adults with difficult-to-treat tumors missing specific genes. These treatments help the immune system attack cancer and stop it from growing. Atezolizumab is an antibody that has been used with other treatments for various cancers.
Recruiting1 award Phase 1 & 214 criteria
More about Fariba Navid, MD
Clinical Trial Related2 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Fariba Navid, MD has experience with
- Larotrectinib
- Palbociclib
- Erdafitinib
- Selpercatinib
- Tipifarnib
- Vemurafenib
Breakdown of trials Fariba Navid, MD has run
Cancer
Relapse
Uterine Tumors
Osteosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fariba Navid, MD specialize in?
Fariba Navid, MD focuses on Cancer and Relapse. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Fariba Navid, MD currently recruiting for clinical trials?
Yes, Fariba Navid, MD is currently recruiting for 5 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Fariba Navid, MD has studied deeply?
Yes, Fariba Navid, MD has studied treatments such as Larotrectinib, Palbociclib, Erdafitinib.
What is the best way to schedule an appointment with Fariba Navid, MD?
Apply for one of the trials that Fariba Navid, MD is conducting.
What is the office address of Fariba Navid, MD?
The office of Fariba Navid, MD is located at: Children's Hospital Los Angeles, Los Angeles, California 90027 United States. This is the address for their practice at the Children's Hospital Los Angeles.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.